购物车
全部删除
您的购物车当前为空
KMT9-IN-1 (Compound 8) 是一种针对KMT9的抑制剂,同时也是化合物7b的乙基酯前药。此化合物在细胞中通过酯酶作用释放出活性形式7b,并与细胞内的KMT9靶向结合,降低H4K12me1水平。KMT9-IN-1 对结肠癌显示出抗肿瘤活性,并且可用于前列腺癌和肝细胞癌的研究。

KMT9-IN-1 (Compound 8) 是一种针对KMT9的抑制剂,同时也是化合物7b的乙基酯前药。此化合物在细胞中通过酯酶作用释放出活性形式7b,并与细胞内的KMT9靶向结合,降低H4K12me1水平。KMT9-IN-1 对结肠癌显示出抗肿瘤活性,并且可用于前列腺癌和肝细胞癌的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
KMT9-IN-1 相关产品
| 产品描述 | KMT9-IN-1 (Compound 8) is a KMT9 inhibitor and an ethyl ester prodrug of compound 7b. Inside cells, KMT9-IN-1 releases the active form 7b through the action of esterases. It specifically associates with the KMT9 target within cells, leading to a reduction in H4K12me1 levels. KMT9-IN-1 exhibits antitumor activity against colon cancer and can be employed in research on prostate cancer and hepatocellular carcinoma. |
| 分子量 | 712.25 |
| 分子式 | C36H47ClFN7O5 |
| CAS No. | 2625406-61-1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容